Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias W Beckmann

Showing results (481-490 of 830) with videos related to

Pageof 83
Sort By:
Breast Care (Basel, Switzerland)|July 12, 2021
Analysis of Oncological Second Opinions in a Certified University Breast and Gynecological Cancer Center Regarding Consensus between the First and Second Opinion and Conformity with the GuidelinesMichael P Lux, Sonja Wasner, Julia Meyer, et al.
The Journal of Pathology. Clinical Research|April 18, 2018
Introducing a novel highly prognostic grading scheme based on tumour budding and cell nest size for squamous cell carcinoma of the uterine cervixMoritz Jesinghaus, Johanna Strehl, Melanie Boxberg, et al.
International Journal of Cancer|April 29, 2026
Chemotherapy-Induced Nausea and Vomiting in Early Breast Cancer Patients Receiving Adjuvant Chemotherapy With Fluorouracil, Epirubicin, Cyclophosphamide Followed by Docetaxel Versus an Anthracycline-Free Regimen With Docetaxel, Cyclophosphamide-Results From a Randomized Clinical TrialManuel Hörner, Henning Schäffler, Lothar Häberle, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|June 15, 2012
Hormone replacement therapy and prognosis in ovarian cancer patientsAlexander Hein, Falk C Thiel, Christian M Bayer, et al.
Breast (Edinburgh, Scotland)|June 22, 2021
Mammographic density and prognosis in primary breast cancer patientsFelix Heindl, Peter A Fasching, Alexander Hein, et al.
Cancers|November 13, 2021
Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular SubtypesRamona Erber, Sareetha Kailayangiri, Hanna Huebner, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 28, 2015
Replication of Epigenetic Postpartum Depression Biomarkers and Variation with Hormone LevelsLauren Osborne, Makena Clive, Mary Kimmel, et al.
Breast Cancer Research and Treatment|August 31, 2012
Shared decision-making in breast cancer: discrepancy between the treatment efficacy required by patients and by physiciansFalk C Thiel, Michael G Schrauder, Peter A Fasching, et al.
Journal of the National Cancer Institute|May 17, 2014
Circulating tumor cells predict survival in early average-to-high risk breast cancer patientsBrigitte Rack, Christian Schindlbeck, Julia Jückstock, et al.
Journal of Cancer Research and Clinical Oncology|December 7, 2010
Diabetes and prognosis in a breast cancer cohortMichael G Schrauder, Peter A Fasching, Lothar Häberle, et al.
Pageof 83

Showing results (481-490 of 830) with videos related to

Sort By:
Pageof 83
Breast Care (Basel, Switzerland)|July 12, 2021
Analysis of Oncological Second Opinions in a Certified University Breast and Gynecological Cancer Center Regarding Consensus between the First and Second Opinion and Conformity with the GuidelinesMichael P Lux, Sonja Wasner, Julia Meyer, et al.
The Journal of Pathology. Clinical Research|April 18, 2018
Introducing a novel highly prognostic grading scheme based on tumour budding and cell nest size for squamous cell carcinoma of the uterine cervixMoritz Jesinghaus, Johanna Strehl, Melanie Boxberg, et al.
International Journal of Cancer|April 29, 2026
Chemotherapy-Induced Nausea and Vomiting in Early Breast Cancer Patients Receiving Adjuvant Chemotherapy With Fluorouracil, Epirubicin, Cyclophosphamide Followed by Docetaxel Versus an Anthracycline-Free Regimen With Docetaxel, Cyclophosphamide-Results From a Randomized Clinical TrialManuel Hörner, Henning Schäffler, Lothar Häberle, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|June 15, 2012
Hormone replacement therapy and prognosis in ovarian cancer patientsAlexander Hein, Falk C Thiel, Christian M Bayer, et al.
Breast (Edinburgh, Scotland)|June 22, 2021
Mammographic density and prognosis in primary breast cancer patientsFelix Heindl, Peter A Fasching, Alexander Hein, et al.
Cancers|November 13, 2021
Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular SubtypesRamona Erber, Sareetha Kailayangiri, Hanna Huebner, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 28, 2015
Replication of Epigenetic Postpartum Depression Biomarkers and Variation with Hormone LevelsLauren Osborne, Makena Clive, Mary Kimmel, et al.
Breast Cancer Research and Treatment|August 31, 2012
Shared decision-making in breast cancer: discrepancy between the treatment efficacy required by patients and by physiciansFalk C Thiel, Michael G Schrauder, Peter A Fasching, et al.
Journal of the National Cancer Institute|May 17, 2014
Circulating tumor cells predict survival in early average-to-high risk breast cancer patientsBrigitte Rack, Christian Schindlbeck, Julia Jückstock, et al.
Journal of Cancer Research and Clinical Oncology|December 7, 2010
Diabetes and prognosis in a breast cancer cohortMichael G Schrauder, Peter A Fasching, Lothar Häberle, et al.
Pageof 83